Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells
Bioscience, Biotechnology, and Biochemistry · 2023
DOI: 10.1093/bbb/zbac197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2023. Verfasst von Maihemuti Mijiti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Life Science, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan. Hauptthemen laut MEDLINE: Lipogenesis, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Fordays Co., Ltd..
Abstract (Originalsprache)
The protamine-derived peptide arginine-proline-arginine (RPR) can ameliorate lifestyle-related diseases such as obesity and hypercholesterolemia. Thus, we hypothesized that the hypolipidemic activity of RPR could attenuate events leading to non-alcoholic fatty liver disease. Addition of 2 m m oleic acid (OA) to the culture medium induced fatty liver conditions in HepG2 cells. The OA + RPR group showed significantly decreased cellular or medium triglyceride (TG) level compared with the OA group. Stearoyl-CoA desaturase-1 (SCD1) or sterol regulatory element-binding protein 1 (SREBP1) protein level was significantly lower in the OA + RPR group than in the OA group. In the R + P + R amino acid mixture-treated group, the TG level was not significantly different from that in the OA-treated group. The OA + RP- or OA + PR-treated groups showed significantly decreased cellular TG level compared with the OA group. Moreover, the effect of RPR disappeared when the peptide transporter 1 (PepT1) was knocked down with a siRNA. Collectively, our results demonstrated that RPR effectively ameliorated hepatic steatosis in HepG2 cells via the PepT1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Life Science, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.
- Fordays Co., Ltd., Fordays Nutritional Research Center, 2-24-16 Nakacho, Koganei City, Tokyo, Japan.
ORCID-Profile: Keita Sutoh, Satoshi Nagaoka
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Fordays Co., Ltd.
Zitieren
APA
Mijiti, M., Mori, R., Nakashima, Y., Banno, A., Ye, Y., Takeuchi, A., Matsuba, S., Kiriyama, K., Sutoh, K., & Nagaoka, S. (2023). Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbac197
Vancouver
Mijiti M, Mori R, Nakashima Y, Banno A, Ye Y, Takeuchi A, et al. Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells. Bioscience, Biotechnology, and Biochemistry. 2023. doi:10.1093/bbb/zbac197
BibTeX
@article{Mijiti2023,
author = {Mijiti, Maihemuti and Mori, Ryosuke and Nakashima, Yuga and Banno, Arata and Ye, Yuyang and Takeuchi, Asahi and Matsuba, Shoya and Kiriyama, Keisuke and Sutoh, Keita and Nagaoka, Satoshi},
title = {Protamine-derived peptide RPR (Arg-Pro-Arg) ameliorates oleic acid-induced lipogenesis via the PepT1 pathway in HepG2 cells},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2023},
doi = {10.1093/bbb/zbac197}
}
EUVIMED